Alexandru Garaiman

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score.

A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score.

Journal: Rheumatology (Oxford, England)

Published: April 14, 2025

Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis.

Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis.

Journal: RMD open

Published: June 13, 2024

Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?

Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?

Journal: RMD open

Published: March 13, 2024

Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database.

Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database.

Journal: Annals of the rheumatic diseases

Published: February 05, 2024

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review.

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review.

Journal: European journal of internal medicine

Published: December 31, 2023

Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed Tomography.

Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed Tomography.

Journal: The Journal of rheumatology

Published: December 04, 2023

Arthritis in patients with very early systemic sclerosis: a comprehensive clinical and prognostic analysis.

Arthritis in patients with very early systemic sclerosis: a comprehensive clinical and prognostic analysis.

Journal: Rheumatology (Oxford, England)

Published: October 16, 2023

Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort.

Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort.

Journal: RMD open

Published: August 29, 2023

The enigma of mixed connective tissue disease-challenges in routine care.

The enigma of mixed connective tissue disease-challenges in routine care.

Journal: Clinical rheumatology

Published: May 19, 2022

Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model.

Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model.

Journal: Rheumatology (Oxford, England)

Published: April 12, 2022

Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.

Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.

Journal: Rheumatology (Oxford, England)

Published: February 22, 2022

The incremental value of the contribution of a biostatistician to the reporting quality in health research-A retrospective, single center, observational cohort study.

The incremental value of the contribution of a biostatistician to the reporting quality in health research-A retrospective, single center, observational cohort study.

Journal: PloS one

Published: December 07, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026